PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
Tesla's FSD advantage could be threatened by BYD's new God's Eye autonomous driving capability. Click here to find out why I ...
Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and ...
Quantum BioPharma (NASDAQ: QNTM) has retained MZHCI, an MZ Group company, to lead its investor relations and financial communications efforts. The in ...
MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...
BYD makes advances in AI-powered driving software while Musk’s wait for approval grows.
Empire is based at 40 Wall Street, New York, New York, United States of America. Empire has been engaged for a period of three months, effective February 7, 2025 (the “ Empire Agreement ”). Pursuant ...
Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ("Lucid ... specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through ...
Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzdTM, signi ...